Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 4Carcinoma, Hepatocellular 2

Interventions

Docetaxel 158Prednisone 131Leuprolide 95bicalutamide 86enzalutamide 83Radiotherapy 80Goserelin 80Abiraterone Acetate 76acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54Magnetic Resonance Spectroscopy 46Zoledronic Acid 44gallium 68 PSMA-11 37Flutamide 34abiraterone 32Estramustine 32radium Ra 223 dichloride 30apalutamide 27Surveys and Questionnaires 26Gonadotropin-Releasing Hormone 26Androgen Antagonists 25cabazitaxel 24Radiosurgery 24Dutasteride 22sipuleucel-T 21Prednisolone 21Triptorelin Pamoate 20Paclitaxel 20luprolide acetate gel depot 19Radiation 19Exercise 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms × fluorocholine × Clear all
NCT02397408 2020-11-19

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

University of California, San Francisco

Phase 2 Completed
18 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

NCT04340765 2020-04-13

18F-fluorocholine and 18F-fluoride PET in Prostate Cancer

Buddhist Tzu Chi General Hospital

Phase NA Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT02840552 2018-08-09

The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer

Sir Mortimer B. Davis - Jewish General Hospital

Phase 3 Completed
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT01993160 2017-01-13

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

University Health Network, Toronto

Phase NA Completed
50 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡